科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/12/19 | 5,100 | 5,100 | 5,040 | 5,080 | -90 | -1.7% | 126,700 |
| 2018/12/18 | 5,250 | 5,250 | 5,170 | 5,170 | -130 | -2.5% | 97,100 |
| 2018/12/17 | 5,330 | 5,340 | 5,270 | 5,300 | -90 | -1.7% | 96,200 |
| 2018/12/14 | 5,350 | 5,450 | 5,350 | 5,390 | -20 | -0.4% | 135,800 |
| 2018/12/13 | 5,390 | 5,460 | 5,370 | 5,410 | +80 | +1.5% | 116,700 |
| 2018/12/12 | 5,310 | 5,360 | 5,260 | 5,330 | +110 | +2.1% | 133,000 |
| 2018/12/11 | 5,340 | 5,370 | 5,200 | 5,220 | -110 | -2.1% | 116,400 |
| 2018/12/10 | 5,320 | 5,370 | 5,290 | 5,330 | -150 | -2.7% | 119,700 |
| 2018/12/07 | 5,390 | 5,490 | 5,340 | 5,480 | +130 | +2.4% | 165,400 |
| 2018/12/06 | 5,460 | 5,480 | 5,330 | 5,350 | -160 | -2.9% | 155,100 |
| 2018/12/05 | 5,530 | 5,550 | 5,490 | 5,510 | -110 | -2% | 156,500 |
| 2018/12/04 | 5,790 | 5,830 | 5,600 | 5,620 | -210 | -3.6% | 160,000 |
| 2018/12/03 | 5,890 | 5,930 | 5,810 | 5,830 | +20 | +0.3% | 105,900 |
| 2018/11/30 | 5,750 | 5,830 | 5,740 | 5,810 | +60 | +1% | 112,200 |
| 2018/11/29 | 5,780 | 5,840 | 5,730 | 5,750 | +40 | +0.7% | 96,700 |
| 2018/11/28 | 5,620 | 5,730 | 5,600 | 5,710 | +100 | +1.8% | 81,900 |
| 2018/11/27 | 5,590 | 5,660 | 5,580 | 5,610 | +30 | +0.5% | 84,000 |
| 2018/11/26 | 5,540 | 5,600 | 5,540 | 5,580 | -10 | -0.2% | 87,100 |
| 2018/11/22 | 5,500 | 5,590 | 5,500 | 5,590 | +90 | +1.6% | 55,500 |
| 2018/11/21 | 5,430 | 5,550 | 5,430 | 5,500 | +10 | +0.2% | 101,900 |
| 2018/11/20 | 5,540 | 5,620 | 5,490 | 5,490 | +40 | +0.7% | 202,800 |
| 2018/11/19 | 5,580 | 5,640 | 5,430 | 5,450 | -70 | -1.3% | 199,500 |
| 2018/11/16 | 5,540 | 5,670 | 5,510 | 5,520 | -10 | -0.2% | 174,900 |
| 2018/11/15 | 5,600 | 5,610 | 5,500 | 5,530 | -110 | -2% | 84,800 |
| 2018/11/14 | 5,700 | 5,720 | 5,630 | 5,640 | -40 | -0.7% | 99,000 |
| 2018/11/13 | 5,680 | 5,720 | 5,650 | 5,680 | -130 | -2.2% | 64,100 |
| 2018/11/12 | 5,780 | 5,860 | 5,780 | 5,810 | +10 | +0.2% | 42,500 |
| 2018/11/09 | 5,800 | 5,850 | 5,780 | 5,800 | +20 | +0.3% | 56,800 |
| 2018/11/08 | 5,850 | 5,850 | 5,770 | 5,780 | +60 | +1% | 68,000 |
| 2018/11/07 | 5,630 | 5,760 | 5,620 | 5,720 | +20 | +0.4% | 84,400 |
| 2018/11/06 | 5,670 | 5,800 | 5,670 | 5,700 | +30 | +0.5% | 76,800 |
| 2018/11/05 | 5,600 | 5,700 | 5,600 | 5,670 | +20 | +0.4% | 70,700 |
| 2018/11/02 | 5,600 | 5,670 | 5,560 | 5,650 | +100 | +1.8% | 84,400 |
| 2018/11/01 | 5,560 | 5,650 | 5,530 | 5,550 | -110 | -1.9% | 116,800 |
| 2018/10/31 | 5,510 | 5,670 | 5,510 | 5,660 | +120 | +2.2% | 94,000 |
| 2018/10/30 | 5,500 | 5,570 | 5,500 | 5,540 | +20 | +0.4% | 102,300 |
| 2018/10/29 | 5,660 | 5,710 | 5,510 | 5,520 | -60 | -1.1% | 76,200 |
| 2018/10/26 | 5,600 | 5,630 | 5,510 | 5,580 | -40 | -0.7% | 97,600 |
| 2018/10/25 | 5,750 | 5,790 | 5,610 | 5,620 | -230 | -3.9% | 99,200 |
| 2018/10/24 | 5,880 | 5,900 | 5,810 | 5,850 | +70 | +1.2% | 70,900 |
| 2018/10/23 | 5,890 | 5,890 | 5,760 | 5,780 | -160 | -2.7% | 84,600 |
| 2018/10/22 | 5,960 | 5,980 | 5,890 | 5,940 | -30 | -0.5% | 50,300 |
| 2018/10/19 | 5,900 | 5,980 | 5,890 | 5,970 | +40 | +0.7% | 92,100 |
| 2018/10/18 | 5,930 | 6,000 | 5,910 | 5,930 | ±0 | ±0% | 72,700 |
| 2018/10/17 | 5,870 | 5,960 | 5,810 | 5,930 | +160 | +2.8% | 83,500 |
| 2018/10/16 | 5,680 | 5,800 | 5,680 | 5,770 | +50 | +0.9% | 73,800 |
| 2018/10/15 | 5,760 | 5,840 | 5,690 | 5,720 | -40 | -0.7% | 102,500 |
| 2018/10/12 | 5,870 | 5,870 | 5,710 | 5,760 | -50 | -0.9% | 145,100 |
| 2018/10/11 | 5,840 | 5,880 | 5,760 | 5,810 | -130 | -2.2% | 119,300 |
| 2018/10/10 | 5,900 | 5,970 | 5,870 | 5,940 | +100 | +1.7% | 101,600 |
1551～
1600
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
